Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Block

Showing results (451-460 of 488) with videos related to

Pageof 49
Sort By:
Biorxiv : the Preprint Server for Biology|April 16, 2025
Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1Vivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Nature Microbiology|October 3, 2025
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemiaVivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
American Journal of Ophthalmology|November 20, 2012
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinionsPaul P Lee, Sheila K West, Sandra S Block, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from MelanomaUgur Sener, Mason Webb, William G Breen, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Plos One|March 21, 2020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutationsThomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 19, 2023
Prescribing patterns for paediatric hyperopia among paediatric eye care providersAnn M Morrison, Marjean T Kulp, Elise B Ciner, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Pageof 49

Showing results (451-460 of 488) with videos related to

Sort By:
Pageof 49
Biorxiv : the Preprint Server for Biology|April 16, 2025
Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1Vivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
Nature Microbiology|October 3, 2025
Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemiaVivek Hariharan, Jennifer A White, Filippo Dragoni, et al.
American Journal of Ophthalmology|November 20, 2012
Surveillance of disparities in vision and eye health in the United States: an expert panel's opinionsPaul P Lee, Sheila K West, Sandra S Block, et al.
Journal of Immunotherapy and Precision Oncology|February 8, 2024
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from MelanomaUgur Sener, Mason Webb, William G Breen, et al.
Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.
Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.
Plos One|March 21, 2020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutationsThomas T DeLeon, Daniel R Almquist, Benjamin R Kipp, et al.
Journal for Immunotherapy of Cancer|June 7, 2020
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|June 19, 2023
Prescribing patterns for paediatric hyperopia among paediatric eye care providersAnn M Morrison, Marjean T Kulp, Elise B Ciner, et al.
Oncoimmunology|December 14, 2020
A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1Neeta Somaiah, Sant P Chawla, Matthew S Block, et al.
Pageof 49